Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech Summit
Provided By PR Newswire
Last update: Apr 2, 2025
SAN DIEGO, April 2, 2025 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that Jay Hagan, CEO, will participate in a presentation at the 2025 Oppenheimer Innovation on the Island Biotech Summit on Wednesday, April 9th at 11:32 a.m. ET.
Read more at prnewswire.com
